Amicus Therapeutics, Inc. (FOLD)
USD 6.72
(3.7%)
USD 6.72
(3.7%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 362.03 Million USD | 21.86% |
| 2022 | 290.63 Million USD | 7.23% |
| 2021 | 271.04 Million USD | 17.93% |
| 2020 | 229.84 Million USD | 43.41% |
| 2019 | 160.27 Million USD | 108.58% |
| 2018 | 76.84 Million USD | 150.35% |
| 2017 | 30.69 Million USD | 644.1% |
| 2016 | 4.12 Million USD | 325.04% |
| 2015 | -1.83 Million USD | -249.75% |
| 2014 | 1.22 Million USD | 109.32% |
| 2013 | -13.12 Million USD | -567.8% |
| 2012 | -1.96 Million USD | -109.17% |
| 2011 | 21.43 Million USD | 2224.73% |
| 2010 | 922 Thousand USD | -98.57% |
| 2009 | 64.35 Million USD | 330.0% |
| 2008 | 14.96 Million USD | 738.96% |
| 2007 | 1.78 Million USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 113.22 Million USD | 19.59% |
| 2024 Q1 | 94.68 Million USD | -6.79% |
| 2023 Q2 | 85.38 Million USD | 7.64% |
| 2023 Q1 | 79.32 Million USD | 0.78% |
| 2023 Q4 | 101.57 Million USD | 8.57% |
| 2023 FY | 354.15 Million USD | 21.86% |
| 2023 Q3 | 93.55 Million USD | 9.56% |
| 2022 Q3 | 68.25 Million USD | -5.9% |
| 2022 Q2 | 72.53 Million USD | 1.97% |
| 2022 Q1 | 71.13 Million USD | -4.27% |
| 2022 FY | 290.63 Million USD | 7.23% |
| 2022 Q4 | 78.71 Million USD | 15.32% |
| 2021 Q3 | 67.84 Million USD | -1.72% |
| 2021 Q1 | 59.86 Million USD | -2.11% |
| 2021 Q4 | 74.3 Million USD | 9.51% |
| 2021 Q2 | 69.03 Million USD | 15.32% |
| 2021 FY | 271.04 Million USD | 17.93% |
| 2020 Q4 | 61.15 Million USD | 3.58% |
| 2020 Q1 | 53.97 Million USD | 11.63% |
| 2020 FY | 229.84 Million USD | 43.41% |
| 2020 Q2 | 55.67 Million USD | 3.16% |
| 2020 Q3 | 59.03 Million USD | 6.04% |
| 2019 Q1 | 29.99 Million USD | 5.98% |
| 2019 Q3 | 43.17 Million USD | 11.37% |
| 2019 Q4 | 48.34 Million USD | 11.99% |
| 2019 FY | 160.27 Million USD | 108.58% |
| 2019 Q2 | 38.76 Million USD | 29.25% |
| 2018 Q4 | 28.3 Million USD | 73.77% |
| 2018 Q2 | 18.17 Million USD | 29.07% |
| 2018 FY | 76.84 Million USD | 150.35% |
| 2018 Q1 | 14.08 Million USD | 16.19% |
| 2018 Q3 | 16.28 Million USD | -10.39% |
| 2017 Q1 | 3.39 Million USD | 44.92% |
| 2017 Q4 | 12.11 Million USD | 33.41% |
| 2017 Q3 | 9.08 Million USD | 48.99% |
| 2017 Q2 | 6.09 Million USD | 79.64% |
| 2017 FY | 30.69 Million USD | 644.1% |
| 2016 Q3 | 1.78 Million USD | 0.0% |
| 2016 Q4 | 2.34 Million USD | 31.35% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | 4.12 Million USD | 325.04% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | -1.83 Million USD | -249.75% |
| 2015 Q2 | -8.74 Million USD | -5.21% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 100.0% |
| 2015 Q1 | -8.3 Million USD | 11.54% |
| 2014 Q1 | -3.65 Million USD | -44.33% |
| 2014 Q4 | -9.39 Million USD | -67.04% |
| 2014 Q3 | -5.62 Million USD | -51.7% |
| 2014 Q2 | -3.7 Million USD | -1.37% |
| 2014 FY | 1.22 Million USD | 109.32% |
| 2013 Q3 | -3.62 Million USD | -23.38% |
| 2013 Q2 | -2.93 Million USD | 28.93% |
| 2013 FY | -13.12 Million USD | -567.8% |
| 2013 Q4 | -2.53 Million USD | 30.12% |
| 2013 Q1 | -4.13 Million USD | -6.93% |
| 2012 Q2 | 10.63 Million USD | 36.83% |
| 2012 FY | -1.96 Million USD | -109.17% |
| 2012 Q3 | 2.11 Million USD | -80.09% |
| 2012 Q4 | -3.86 Million USD | -282.53% |
| 2012 Q1 | 7.77 Million USD | 38.08% |
| 2011 Q4 | 5.63 Million USD | -2.9% |
| 2011 FY | 21.43 Million USD | 2224.73% |
| 2011 Q1 | 5.96 Million USD | 547.07% |
| 2011 Q2 | 4.04 Million USD | -32.28% |
| 2011 Q3 | 5.79 Million USD | 43.51% |
| 2010 Q4 | 922 Thousand USD | 0.0% |
| 2010 FY | 922 Thousand USD | -98.57% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2009 Q4 | 49.47 Million USD | 907.04% |
| 2009 Q2 | 5.36 Million USD | 16.39% |
| 2009 Q1 | 4.6 Million USD | 6.01% |
| 2009 FY | 64.35 Million USD | 330.0% |
| 2009 Q3 | 4.91 Million USD | -8.36% |
| 2008 FY | 14.96 Million USD | 738.96% |
| 2008 Q4 | 4.34 Million USD | 18.94% |
| 2008 Q3 | 3.65 Million USD | -4.05% |
| 2008 Q2 | 3.8 Million USD | 20.47% |
| 2008 Q1 | 3.16 Million USD | 77.13% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | 1.78 Million USD | 0.0% |
| 2007 FY | 1.78 Million USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | -159.306% |
| Immix Biopharma, Inc. | -5468.00 USD | 6620985.15% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 54622.59% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 566.546% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 68796.395% |
| MiMedx Group, Inc. | 266.84 Million USD | -35.672% |
| Novavax, Inc. | 639.93 Million USD | 43.427% |
| Seer, Inc. | 7.02 Million USD | -5051.985% |
| Acelyrin, Inc. | -115 Thousand USD | 314908.696% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -167.637% |
| IO Biotech, Inc. | -756 Thousand USD | 47987.566% |
| Ardelyx, Inc. | 106.66 Million USD | -239.421% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 473.419% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1261.557% |
| Fortress Biotech, Inc. | 57.85 Million USD | -525.776% |
| Fortress Biotech, Inc. | 57.85 Million USD | -525.776% |
| Geron Corporation | -123.5 Million USD | 393.135% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -50.385% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -2083.93% |
| Incyte Corporation | 3.44 Billion USD | 89.478% |
| Innoviva, Inc. | 261.06 Million USD | -38.674% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 658336.364% |
| ChromaDex Corporation | 50.78 Million USD | -612.938% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -202.314% |
| MEI Pharma, Inc. | 49.32 Million USD | -633.939% |
| NextCure, Inc. | -3.68 Million USD | 9927.09% |
| Onconetix, Inc. | -1.12 Million USD | 32218.634% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1349.758% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 252736.06% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 441.142% |
| Vaxcyte, Inc. | -75 Million USD | 582.707% |
| Precigen, Inc. | 106 Thousand USD | -341437.736% |
| Pharming Group N.V. | 220.1 Million USD | -64.481% |
| ContextLogic Inc. | 59 Million USD | -513.61% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 156147.414% |
| Pyxis Oncology, Inc. | -2 Million USD | 18201.5% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -229.802% |
| AlloVir, Inc. | -398 Thousand USD | 91062.312% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1146.016% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 3602030.156% |
| Summit Therapeutics Inc. | -2.05 Million USD | 17760.0% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 3017016.667% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 63502.802% |
| Senti Biosciences, Inc. | -2.68 Million USD | 13593.477% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -301591.667% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 7645.436% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -1142.851% |
| Psyence Biomedical Ltd. | -240.00 USD | 150845933.333% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 819394.831% |
| Chimerix, Inc. | 324 Thousand USD | -111637.654% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 631628.451% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 441600.0% |
| CRISPR Therapeutics AG | 240.95 Million USD | -50.247% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -247.775% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -70197.087% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -35780.079% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 9905.796% |
| Precision BioSciences, Inc. | 40.47 Million USD | -794.52% |
| Dyadic International, Inc. | 922.95 Thousand USD | -39125.013% |
| Elevation Oncology, Inc. | -39 Thousand USD | 928382.051% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1618.959% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -200.505% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 76.149% |
| Aptorum Group Limited | -1.11 Million USD | 32578.146% |
| Bicycle Therapeutics plc | -129.52 Million USD | 379.517% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 9283.805% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -4499.543% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 2810.242% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 73.664% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -8169.301% |
| Jaguar Health, Inc. | 7.72 Million USD | -4587.079% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -72889.919% |
| AbCellera Biologics Inc. | 38.02 Million USD | -852.084% |
| PureTech Health plc | -1.6 Million USD | 22684.529% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 70159.565% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 898.742% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -45040.898% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1580.343% |
| AnaptysBio, Inc. | 14.78 Million USD | -2349.293% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1679.606% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 305633.754% |
| Molecular Templates, Inc. | 50.39 Million USD | -618.385% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -1131.939% |
| Vaxxinity, Inc. | -2.23 Million USD | 16305.461% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 73683.333% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1746.564% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 872.924% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 38241.584% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 7240700.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -8836.806% |
| ImmuCell Corporation | 4.39 Million USD | -8134.909% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 207160.048% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -85284.434% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1801.119% |
| Opthea Limited | 21.72 Thousand USD | -1666704.788% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 299.567% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 468.602% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 468.805% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -59346.634% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -15.417% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -13964.88% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 713600.197% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 5200.451% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 76389.92% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 3481157.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -371933.994% |
| Century Therapeutics, Inc. | -10.8 Million USD | 3449.339% |
| Kura Oncology, Inc. | -849 Thousand USD | 42741.932% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 639.506% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 246378.912% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -265.543% |
| Autolus Therapeutics plc | -4.86 Million USD | 7538.463% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -774.764% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 215594.048% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -282.199% |
| GRI Bio, Inc. | 10.84 Million USD | -3239.452% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -14153.228% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 4267.492% |
| IGM Biosciences, Inc. | -211.66 Million USD | 271.043% |
| INmune Bio, Inc. | 155 Thousand USD | -233467.742% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -484.494% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 24134.533% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 55929.712% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1236794.678% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -89957.214% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 18237.776% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 115764.537% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -283.259% |
| Verastem, Inc. | -62 Thousand USD | 584019.355% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -14767.762% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 138808.812% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -11860.026% |
| Histogen Inc. | 3.76 Million USD | -9505.466% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -62732.904% |
| Surrozen, Inc. | -27.23 Million USD | 1429.526% |
| Organovo Holdings, Inc. | -5.38 Million USD | 6817.944% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 30146.976% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1511.588% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1705.456% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 18284443.434% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -5867.767% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 539388.853% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -133.883% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -248205.898% |
| Apollomics, Inc. | 127 Thousand USD | -284962.992% |
| Amarin Corporation plc | 165.54 Million USD | -118.695% |
| Mesoblast Limited | -9.81 Million USD | 3788.538% |
| Turnstone Biologics Corp. | 16.5 Million USD | -2093.324% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 427.662% |
| Synaptogenix, Inc. | -6347.00 USD | 5704054.624% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 709962.745% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -124.355% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 79.403% |
| Better Therapeutics, Inc. | -2.72 Million USD | 13366.032% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 422.777% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -7.084% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3173574.755% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 5883.227% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 32774.188% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -4847.116% |
| Insmed Incorporated | 239.63 Million USD | -51.076% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -10018.222% |
| OmniAb, Inc. | 14.66 Million USD | -2368.33% |
| Alector, Inc. | -95.05 Million USD | 480.872% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -188.192% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 932.961% |
| Zai Lab Limited | 170.9 Million USD | -111.834% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -342.163% |
| Aura Biosciences, Inc. | -1.29 Million USD | 28055.985% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -278384.615% |
| Immunic, Inc. | -111 Thousand USD | 326253.153% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -2183.525% |
| Veracyte, Inc. | 248.14 Million USD | -45.893% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 105.18% |
| FibroGen, Inc. | 128.9 Million USD | -180.852% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 64189816.312% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 3203.056% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 89.348% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -92966.838% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -1.881% |
| TG Therapeutics, Inc. | 219.1 Million USD | -65.229% |
| Galecto, Inc. | -830 Thousand USD | 43718.072% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 26239.35% |
| Fortrea Holdings Inc. | 424 Million USD | 14.616% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 520.149% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 63950.088% |
| XBiotech Inc. | -1.74 Million USD | 20858.601% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 32774.188% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 879.045% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 579.294% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -393.209% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -2054.556% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 6.943% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 829.208% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -10.797% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 3297.06% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1380.635% |
| NexImmune, Inc. | -1.02 Million USD | 35420.965% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -6704159.259% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 5194.955% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 96.797% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 541842.11% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 10295.156% |
| Ainos, Inc. | -253.73 Thousand USD | 142781.48% |
| Pluri Inc. | 322 Thousand USD | -112331.677% |
| Prothena Corporation plc | -129.2 Million USD | 380.207% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -617.972% |
| Celularity Inc. | 6.75 Million USD | -5259.437% |
| Rallybio Corporation | -150 Thousand USD | 241453.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1210.283% |
| MeiraGTx Holdings plc | 287 Thousand USD | -126042.857% |
| Omeros Corporation | -69.77 Million USD | 618.824% |
| Humacyte, Inc. | -76.55 Million USD | 572.933% |
| Immunocore Holdings plc | 248.39 Million USD | -45.75% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 2486.644% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -480.344% |
| Blueprint Medicines Corporation | 236.58 Million USD | -53.024% |
| CalciMedica, Inc. | -58 Thousand USD | 624289.655% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 25487.798% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 12829.606% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1272.947% |
| Pulmatrix, Inc. | -8.22 Million USD | 4504.258% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 31042.735% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 90834.336% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 190.781% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -12943.376% |
| Cytokinetics, Incorporated | -322.59 Million USD | 212.225% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -41893.725% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 106267.155% |
| Vor Biopharma Inc. | -3.49 Million USD | 10467.411% |
| Roivant Sciences Ltd. | 109.23 Million USD | -231.423% |
| Evogene Ltd. | 1.39 Million USD | -25777.77% |
| ProKidney Corp. | -3.16 Million USD | 11524.109% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 924.444% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -5179.714% |
| CorMedix Inc. | -205.56 Thousand USD | 176217.181% |
| BioLineRx Ltd. | 1.1 Million USD | -32574.188% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 560.182% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1097160.606% |
| Atai Life Sciences N.V. | -5000.00 USD | 7240700.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 297189.259% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 377214.583% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 26164.075% |
| Sagimet Biosciences Inc. | 2 Million USD | -18001.5% |
| MediciNova, Inc. | 979.7 Thousand USD | -36852.96% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 529.358% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 382977.69% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1847.184% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -48.048% |
| Biomea Fusion, Inc. | -4.2 Million USD | 8717.71% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 58.499% |
| Mereo BioPharma Group plc | 7.42 Million USD | -4775.168% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 116883.871% |
| Absci Corporation | -41.84 Million USD | 965.086% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 7240700.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 574.029% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 14810.687% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -69.383% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 38572.901% |
| Allakos Inc. | -6.14 Million USD | 5995.294% |
| Imunon, Inc. | -720 Thousand USD | 50381.595% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 624.712% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 23.926% |
| BioAtla, Inc. | -103.73 Million USD | 449.008% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3173574.755% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 203487.64% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 249.095% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 116508.36% |
| XOMA Corporation | 3.86 Million USD | -9276.586% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 616.558% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -2347.141% |
| aTyr Pharma, Inc. | -2.38 Million USD | 15260.385% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -2805.538% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1248479.31% |
| Viridian Therapeutics, Inc. | -1 Million USD | 36015.675% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2784846053.846% |
| Akari Therapeutics, Plc | -4000.00 USD | 9050850.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 43.157% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -185834.836% |
| UroGen Pharma Ltd. | 73.35 Million USD | -393.552% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1456.222% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -3118160.121% |
| Orgenesis Inc. | -5.72 Million USD | 6423.668% |
| Entera Bio Ltd. | -56 Thousand USD | 646582.143% |
| GH Research PLC | -315 Thousand USD | 115030.159% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 191650.265% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 69058.095% |
| Xencor, Inc. | -85.26 Million USD | 524.619% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 163931.53% |
| Replimune Group, Inc. | -2.65 Million USD | 13735.782% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 36258.308% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -103.566% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -185834.836% |
| Portage Biotech Inc. | -54 Thousand USD | 670525.926% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 382977.69% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 96129.178% |
| OncoCyte Corporation | 413 Thousand USD | -87558.596% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 8054160.067% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 163076676.577% |
| Purple Biotech Ltd. | -196 Thousand USD | 184809.184% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -3936.909% |
| scPharmaceuticals Inc. | 9.78 Million USD | -3600.981% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 3566.075% |
| HilleVax, Inc. | -2.15 Million USD | 16891.744% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 373326.804% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 2412989.896% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 54296.108% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1574143.478% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 4823205.29% |
| Savara Inc. | -44.26 Million USD | 917.925% |
| Curis, Inc. | 9.81 Million USD | -3590.042% |
| Daré Bioscience, Inc. | 2.76 Million USD | -12971.931% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 290216.037% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 21038.693% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 158885.088% |
| BeiGene, Ltd. | 2.07 Billion USD | 82.585% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 13048.603% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 190.584% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -538.636% |
| Erasca, Inc. | -3.73 Million USD | 9800.697% |
| bluebird bio, Inc. | -4.03 Million USD | 9083.375% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1283075.406% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 80.99% |
| DBV Technologies S.A. | 15.72 Million USD | -2201.818% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1283075.406% |
| Moderna, Inc. | 2.15 Billion USD | 83.2% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 39666.12% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -4421.984% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 67642.91% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -170.6% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 5918.547% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1020.189% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 425.777% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 10190.022% |
| MacroGenics, Inc. | 50.52 Million USD | -616.508% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 6036.865% |
| Prime Medicine, Inc. | -147.9 Million USD | 344.772% |
| Aditxt, Inc. | -111.66 Thousand USD | 324325.327% |
| Adagene Inc. | 18.11 Million USD | -1898.897% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -74086.475% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -158.22% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -129.371% |
| SciSparc Ltd. | 2.19 Million USD | -16385.883% |
| Vericel Corporation | 135.57 Million USD | -167.031% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1445387.237% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1168617.204% |
| Generation Bio Co. | -73.91 Million USD | 589.819% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 82944.394% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -562.828% |
| Invivyd, Inc. | -2.02 Million USD | 17951.578% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 220.339% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 350097.1% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -275.674% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -268.336% |
| ADMA Biologics, Inc. | 88.21 Million USD | -310.381% |
| Clene Inc. | 533 Thousand USD | -67823.077% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1401.627% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 37929.676% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1847.184% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -18110.765% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 186409.928% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -626.895% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 5204.766% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 43405.024% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -334.011% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -495071.791% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -580.994% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 309.039% |
| Trevena, Inc. | 1.45 Million USD | -24781.787% |
| Surrozen, Inc. | -27.23 Million USD | 1429.526% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 102658.074% |
| Cingulate Inc. | -582.91 Thousand USD | 62206.506% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1167938.71% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1937.809% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 4782530.647% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 41193.076% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 46.816% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 36742.713% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 642657.95% |
| Kronos Bio, Inc. | 1.37 Million USD | -26287.026% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 774.598% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 124082.877% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 74238.771% |
| ImmunityBio, Inc. | -17.89 Million USD | 2123.644% |
| Korro Bio, Inc. | -3.63 Million USD | 10073.278% |
| Kineta, Inc. | 5.43 Million USD | -6563.538% |
| BioVie Inc. | -229.37 Thousand USD | 157931.866% |
| Codexis, Inc. | 57.33 Million USD | -531.44% |
| Celularity Inc. | 6.75 Million USD | -5259.437% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -8921.43% |
| Celcuity Inc. | -142.77 Thousand USD | 253672.129% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -715515.734% |
| Cibus, Inc. | 1.42 Million USD | -25359.212% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 96899.465% |
| IN8bio, Inc. | -2.5 Million USD | 14575.41% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1495.267% |
| Annexon, Inc. | -3.26 Million USD | 11181.42% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 17811.84% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 967.408% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -56467.188% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 53.497% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -109.32% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 19154.211% |
| Arcellx, Inc. | 108.27 Million USD | -234.349% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1218.447% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -357.086% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1811.564% |
| Moolec Science SA | -143.3 Thousand USD | 252729.008% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 955.499% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -10913.995% |
| Royalty Pharma plc | 1.79 Billion USD | 79.819% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 616.522% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 10023078.959% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -156358.116% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 424.941% |
| Humacyte, Inc. | -76.55 Million USD | 572.933% |
| 89bio, Inc. | -273 Thousand USD | 132711.722% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 28901.114% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 42792.217% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 294433.333% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -32252.994% |
| Notable Labs, Ltd. | 113 Thousand USD | -320280.531% |
| Liquidia Corporation | 14.6 Million USD | -2379.658% |
| Mustang Bio, Inc. | -2.22 Million USD | 16371.011% |
| Immunovant, Inc. | -231 Thousand USD | 156822.944% |
| Quantum-Si incorporated | 488 Thousand USD | -74086.475% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 751.614% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1206866.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -19343.072% |
| Acasti Pharma Inc. | -11 Thousand USD | 3291281.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 177030.558% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 55929.712% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 316.122% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -31808.724% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 95120.997% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 18589.785% |
| PepGen Inc. | -1.18 Million USD | 30676.858% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 285162.992% |
| United Therapeutics Corporation | 2.07 Billion USD | 82.511% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1681.124% |
| Solid Biosciences Inc. | -76.56 Million USD | 572.852% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 438483.202% |
| Immuneering Corporation | -764.13 Thousand USD | 47477.568% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -546244.923% |
| Belite Bio, Inc | -399 Thousand USD | 90834.336% |
| XOMA Corporation | 3.86 Million USD | -9276.586% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1906.898% |
| Bionomics Limited | -434.44 Thousand USD | 83430.84% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 33808.566% |
| uniQure N.V. | 2.21 Million USD | -16244.47% |
| Cassava Sciences, Inc. | -89.42 Million USD | 504.851% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 493.216% |
| Forte Biosciences, Inc. | -9000.00 USD | 4022655.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 43456.886% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 82944.394% |
| Altimmune, Inc. | -65.37 Million USD | 653.791% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 33808.566% |
| Compugen Ltd. | 31.45 Million USD | -1050.946% |
| Peak Bio, Inc. | 367.76 Thousand USD | -98339.51% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1376.709% |
| Benitec Biopharma Inc. | 108 Thousand USD | -335112.963% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 464241.026% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 30193.932% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 19969.923% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 304326.891% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 30193.932% |
| Instil Bio, Inc. | -4.75 Million USD | 7712.069% |
| argenx SE | 1.1 Billion USD | 67.34% |
| Immunome, Inc. | -8.9 Million USD | 4164.556% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 19255.026% |
| Verona Pharma plc | -679.62 Thousand USD | 53369.161% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 206974.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 15279.455% |
| CervoMed Inc. | -1.29 Million USD | 28085.656% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 15140.715% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 7678.606% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -14551.153% |
| Moolec Science SA | -143.3 Thousand USD | 252729.008% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 88826.319% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 13651.421% |
| Design Therapeutics, Inc. | -537 Thousand USD | 67517.132% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 84884.543% |
| NeurAxis, Inc. | 2.15 Million USD | -16686.263% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -16769.991% |
| Lumos Pharma, Inc. | 2 Million USD | -17938.366% |
| Achilles Therapeutics plc | -4.73 Million USD | 7751.862% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 206974.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 342688.124% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1043.538% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -41893.725% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 35180.426% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 894.832% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -841830.233% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 44142.579% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 2751505.989% |
| Palisade Bio, Inc. | 246 Thousand USD | -147066.667% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1097160.606% |
| Beam Therapeutics Inc. | -59.67 Million USD | 706.7% |
| Neurogene Inc. | -3.26 Million USD | 11198.406% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -159.827% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -805.075% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 121995.623% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 9089.984% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 3884.549% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -2471.236% |
| Athira Pharma, Inc. | -969 Thousand USD | 37461.197% |
| Vaccinex, Inc. | -16 Million USD | 2362.122% |
| HCW Biologics Inc. | -574.82 Thousand USD | 63081.017% |
| XOMA Corporation | 3.86 Million USD | -9276.586% |
| Nektar Therapeutics | 53.47 Million USD | -576.97% |
| Arvinas, Inc. | 71.8 Million USD | -404.22% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 533.771% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 676.71% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 112531.677% |
| Rezolute, Inc. | -36 Thousand USD | 1005738.889% |
| Clene Inc. | 533 Thousand USD | -67823.077% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 28195582.866% |
| BeyondSpring Inc. | 1.75 Million USD | -20575.614% |
| Synlogic, Inc. | -1.92 Million USD | 18916.528% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 978559.459% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 5817.467% |
| Peak Bio, Inc. | 367.76 Thousand USD | -98339.51% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 2009.139% |
| Krystal Biotech, Inc. | 47.6 Million USD | -660.487% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -156.593% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -7104.577% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 14082.209% |
| MannKind Corporation | 136.19 Million USD | -165.825% |
| Ikena Oncology, Inc. | -50.49 Million USD | 817.005% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -232.705% |
| Gossamer Bio, Inc. | -4.38 Million USD | 8356.1% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 143762.698% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 7240700.0% |
| Legend Biotech Corporation | 140.92 Million USD | -156.888% |
| Mural Oncology plc | -2.56 Million USD | 14203.233% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 65804.174% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 362130.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1644.387% |
| REGENXBIO Inc. | 53.02 Million USD | -582.702% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 6858.133% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 188289.734% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 21002.425% |
| Vaxart, Inc. | -60.76 Million USD | 695.807% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 137869.237% |
| Cellectis S.A. | 18 Thousand USD | -2011177.778% |
| Longeveron Inc. | 221 Thousand USD | -163714.48% |
| Repare Therapeutics Inc. | -80.07 Million USD | 552.142% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 66.877% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 28077.589% |
| Revolution Medicines, Inc. | -399.66 Million USD | 190.584% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1034471.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -738736.735% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 95.794% |
| Denali Therapeutics Inc. | -93.34 Million USD | 487.841% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1445387.237% |
| Veru Inc. | 7.56 Million USD | -4685.005% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 239854.967% |
| Cingulate Inc. | -582.91 Thousand USD | 62206.506% |
| Passage Bio, Inc. | -3.72 Million USD | 9829.374% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 3005995.051% |
| Exicure, Inc. | -1.42 Million USD | 25541.321% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 94624.804% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -13293.637% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 70715.887% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -431.412% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 242087.34% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 711.475% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -92490.793% |
| OmniAb, Inc. | 14.66 Million USD | -2368.33% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1710.784% |
| Lipocine Inc. | -2.85 Million USD | 12799.162% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 19743.516% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 6445.837% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 24134.533% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -380.681% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 557069.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -329.475% |
| Ocugen, Inc. | -33.53 Million USD | 1179.494% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 11549.399% |
| Q32 Bio Inc. | 578 Thousand USD | -62534.948% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 136715.094% |
| Alumis Inc. Common Stock | -1.28 Million USD | 28295.483% |
| Equillium, Inc. | 35.95 Million USD | -906.814% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 21308.553% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -72207.806% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 8757477.842% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 139879.923% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -85544.6% |
| Dominari Holdings Inc. | 2.03 Million USD | -17655.272% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 197422.738% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2762.964% |
| Bio-Techne Corporation | 773.07 Million USD | 53.17% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1990.363% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 21.432% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 31069.204% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1609.716% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2995.067% |
| Nkarta, Inc. | -5.86 Million USD | 6268.513% |
| BioCardia, Inc. | -7.24 Million USD | 5094.206% |
| Iterum Therapeutics plc | -1.75 Million USD | 20787.429% |